ArticleCureus2025
Papillary Thyroid Carcinoma Presenting as Multinodular Goiter With Possible Metastasis: A Case Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multinodular goiter (MNG), which may be caused by a variety of risk factors, is typically incidentally found. It is not uncommon for an incidental finding of MNG to lead to a diagnosis of papillary thyroid carcinoma (PTC); however, close monitoring for metastasis is necessary in high-risk patients. Herein, we present the case of a 71-year-old male, seemingly following a normal path of incidental discovery of MNG leading to PTC upon thyroid ultrasound and fine-needle aspiration (FNA) biopsy diagnostic exams. A total thyroidectomy was performed, with pathology confirming an aggressive tumor type (tall cell variant, T4a). Postoperative findings revealed extrathyroidal extension (ETE) with possible lung metastasis. Complications such as these highlight the importance of closely monitoring patients with a higher risk of aggressive thyroid cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.